mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb®)

✍ Scribed by Alejandro Vázquez-Martín; Cristina Oliveras-Ferraros; Sonia del Barco; Begoña Martín-Castillo; Javier A. Menéndez

• Book ID: 107596536
• Publisher: Springer Milan
• Year: 2009
• Tongue: Spanish
• Weight: 470 KB
• Volume: 11
• Category: Article
• ISSN: 1699-048X
• DOI: 10.1007/s12094-009-0384-0